These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma. Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459 [TBL] [Abstract][Full Text] [Related]
8. BAP1 germline mutation in two first grade family members with uveal melanoma. Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051 [TBL] [Abstract][Full Text] [Related]
9. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004 [TBL] [Abstract][Full Text] [Related]
10. BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma. Zhang C; Wu S Mol Med; 2023 Sep; 29(1):126. PubMed ID: 37710185 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma. Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622 [TBL] [Abstract][Full Text] [Related]
12. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425 [TBL] [Abstract][Full Text] [Related]
13. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma. Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891 [TBL] [Abstract][Full Text] [Related]
15. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma. Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262 [TBL] [Abstract][Full Text] [Related]
16. [Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches]. Zhilnikova MV; Troitskaya OS; Novak DD; Atamanov VV; Koval OA Mol Biol (Mosk); 2024; 58(2):189-203. PubMed ID: 39355878 [TBL] [Abstract][Full Text] [Related]
17. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes. Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562 [TBL] [Abstract][Full Text] [Related]
18. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations. Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E; Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551 [TBL] [Abstract][Full Text] [Related]
19. Verification of EZH2 as a druggable target in metastatic uveal melanoma. Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma. Akin-Bali DF Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]